Synapse

← The Lancet Regional Health - Europe

Papers in The Lancet Regional Health - Europe

Page 8 · newest first

  1. Long-term outcomes of untreated cerebral cavernous malformations: a prospective, population-based cohort studyThe Lancet Regional Health - Europe · 2025
  2. Italy’s NITAG shift: implications for public trust in vaccinesThe Lancet Regional Health - Europe · 2025
  3. Long–term effects of gastric bypass and sleeve gastrectomy in type 2 diabetes: a matched retrospective cohort study from SwedenThe Lancet Regional Health - Europe · 2025
  4. The IGRA Paradox: a landmark development but with important lessons still to learnThe Lancet Regional Health - Europe · 2025
  5. Changing clinical perspectives on sex and healthcare disparities in ischaemic heart diseaseThe Lancet Regional Health - Europe · 2025
  6. Challenges in the prevention, treatment and management of cardiovascular disease among older adultsThe Lancet Regional Health - Europe · 2025
  7. Mental health disorders and their impact on cardiovascular health disparitiesThe Lancet Regional Health - Europe · 2025
  8. Reducing inequalities in cardiovascular disease: focus on marginalized populations considering ethnicity and raceThe Lancet Regional Health - Europe · 2025
  9. Equity and cardiovascular disease: time to take it seriouslyThe Lancet Regional Health - Europe · 2025
  10. Addressing cardiovascular health disparities: global perspectives from the patient communityThe Lancet Regional Health - Europe · 2025
  11. Risk factors for dementia and cognitive impairment within 5 years after stroke: a prospective multicentre cohort studyThe Lancet Regional Health - Europe · 2025
  12. Spatio-temporal trends and socio-environmental determinants of suicides in England (2002–2022): an ecological population-based studyThe Lancet Regional Health - Europe · 2025
  13. Uptake, positivity, and equity of online postal self-sampling for chlamydia testing in England: a retrospective cohort studyThe Lancet Regional Health - Europe · 2025
  14. Trends over 48 years in a one-number index of survival for all cancers combined, England and Wales (1971–2018): a population-based registry studyThe Lancet Regional Health - Europe · 2025
  15. 5-Year conditional relative survival of adolescents and young adults with solid malignancies in the Netherlands: a population-based cohort studyThe Lancet Regional Health - Europe · 2025
  16. Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in SpainThe Lancet Regional Health - Europe · 2025
  17. Artificial Intelligence in migrant health: a critical perspective on opportunities and risksThe Lancet Regional Health - Europe · 2025
  18. Eculizumab withdrawal and monitoring in atypical haemolytic uraemic syndrome (SETS aHUS): a multicentre, open label, prospective, single arm trialThe Lancet Regional Health - Europe · 2025
  19. High-dose use of pregabalin and gabapentin in France: a retrospective, population-based cohort studyThe Lancet Regional Health - Europe · 2025
  20. Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet studyThe Lancet Regional Health - Europe · 2025
  21. Cardiovascular safety of biologic therapies in patients with severe asthma: a nationwide cohort study in BelgiumThe Lancet Regional Health - Europe · 2025
  22. Socioeconomic disparities in incidence, treatment, and survival of intrahepatic cholangiocarcinoma: insights from a nationwide cohort study in SwedenThe Lancet Regional Health - Europe · 2025
  23. Safety and efficacy of rotigotine in patients with frontotemporal dementia: a phase 2, double-blind, randomized, placebo-controlled, multicenter trialThe Lancet Regional Health - Europe · 2025
  24. From waste to sustainability: a European call to action on responsible disposal of unused and expired household medicationsThe Lancet Regional Health - Europe · 2025
  25. Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer AssociationThe Lancet Regional Health - Europe · 2025
  26. Clinical presentation, management and outcome of 11132 patients with liposarcoma: a population-based study from the NETSARC+ registryThe Lancet Regional Health - Europe · 2025
  27. Nasogastric tube after oesophagectomy and risk of anastomotic leak: a Nordic, multicentre, open-label, randomised, controlled, non-inferiority trialThe Lancet Regional Health - Europe · 2025
  28. Cause-specific mortality in individuals with and without mental disorders according to socioeconomic position: a population-based cohort studyThe Lancet Regional Health - Europe · 2025
  29. Association between socioeconomic factors and semaglutide use for weight loss: a population-based cross-sectional study in DenmarkThe Lancet Regional Health - Europe · 2025
  30. Trends in epilepsy mortality of three incidence cohorts across 2006–2023 in Sweden: a matched register-based studyThe Lancet Regional Health - Europe · 2025
  31. Out-of-home care placement, psychiatric disorders, and risk of homelessness: a population-based cohort studyThe Lancet Regional Health - Europe · 2025
  32. Evaluation of a national digital pre-implantation biopsy service for deceased-donor kidney transplantation in the UK (Pithia trial): a stepped-wedge cluster randomised registry trialThe Lancet Regional Health - Europe · 2025
  33. Excess mortality and hospitalisations associated with respiratory syncytial virus, influenza, and COVID-19 among adults in Denmark (2015–2024): a modelling studyThe Lancet Regional Health - Europe · 2025
  34. Can predicting future pregnancies after loss personalise miscarriage care?The Lancet Regional Health - Europe · 2025
  35. Primary endpoint acceptance and its association with benefit ratings and market access in German health technology assessments: a retrospective cohort studyThe Lancet Regional Health - Europe · 2025
  36. Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort studyThe Lancet Regional Health - Europe · 2025
  37. Secondary prevention of cardiovascular disease: is it time for the polypill to be standard treatment?The Lancet Regional Health - Europe · 2025
  38. COVID-19 infection and severity among childhood cancer survivors in Denmark and Sweden: a register-based cohort study with matched population and sibling comparisonsThe Lancet Regional Health - Europe · 2025
  39. Game of stones: making a decision about economic value of a weight-loss interventionThe Lancet Regional Health - Europe · 2025
  40. Progression of biological markers in spinocerebellar ataxia type 3: longitudinal analysis of prospective data from the ESMI cohortThe Lancet Regional Health - Europe · 2025
  41. The impact of domestic abuse on suicideThe Lancet Regional Health - Europe · 2025
  42. Cancelled elective operations and 28-day breaches in the NHS in England: an interrupted time series analysis of the 2002 penalty policy, 2008 recession, and COVID-19 pandemic (1994–2023)The Lancet Regional Health - Europe · 2025
  43. Cost-effectiveness of vaccination strategies to control future mpox outbreaks in England: a modelling studyThe Lancet Regional Health - Europe · 2025
  44. The importance of longitudinal observational studies for hereditary neurodegenerative disordersThe Lancet Regional Health - Europe · 2025
  45. Advancing Europe's non-communicable diseases agenda through cross-national collaboration: translating WHO-Europe findings into actionable strategiesThe Lancet Regional Health - Europe · 2025
  46. Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trialThe Lancet Regional Health - Europe · 2025
  47. Evolution of nicotine product use in Ireland 2015–2023, and associations with quit intentions and attempts: an analysis of nationally representative repeated cross-sectional surveysThe Lancet Regional Health - Europe · 2025
  48. Management of non-traumatic abdominal pain in the emergency department: a multicentre, stepped-wedge, cluster-randomised trialThe Lancet Regional Health - Europe · 2025
  49. Fertility, time to pregnancy, and pregnancy outcomes among women with recurrent miscarriages in the UK: a prospective observational longitudinal studyThe Lancet Regional Health - Europe · 2025
  50. Model of care for individuals with rare cancer predisposition syndromes in GermanyThe Lancet Regional Health - Europe · 2025